Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENDEL: Evolocumab Monotherapy in Hypercholesterolemia
NCT01375777Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2011
- Primary completion
- Mar 2012
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of evolocumab in hypercholesterolemia, sponsored by Amgen. Started Jul 2011; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01375777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01375777.